💎2018 #Recommendations for the treatment of confirmed #hypertension in people with #diabetes💎
✨ Join Us✨👇
📲 @IRathero💫
✨ Join Us✨👇
📲 @IRathero💫
انجمن آترواسکلروز ایران(IRSA)
💎2018 #Recommendations for the treatment of confirmed #hypertension in people with #diabetes💎 ✨ Join Us✨👇 📲 @IRathero💫
🔗#توضیحات #شکل بالا
💎2018 #Recommendations for the treatment of confirmed #hypertension in people with #diabetes💎
*An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension for patients with UACR 30–299 mg/g creatinine and strongly recommended for patients with UACR ≥300 mg/g creatinine.
Thiazide-like diuretic; long-acting agents shown to reduce cardiovascular events, such as chlorthalidone and indapamide, are preferred.
*Dihydropyridine calcium channel #blocker. BP, blood pressure.
❣ This figure can also be found in the ADA position statement “#Diabetes and #Hypertension”
✨ Join Us✨👇
📲 @IRathero💫
💎2018 #Recommendations for the treatment of confirmed #hypertension in people with #diabetes💎
*An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension for patients with UACR 30–299 mg/g creatinine and strongly recommended for patients with UACR ≥300 mg/g creatinine.
Thiazide-like diuretic; long-acting agents shown to reduce cardiovascular events, such as chlorthalidone and indapamide, are preferred.
*Dihydropyridine calcium channel #blocker. BP, blood pressure.
❣ This figure can also be found in the ADA position statement “#Diabetes and #Hypertension”
✨ Join Us✨👇
📲 @IRathero💫
✅ #EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
✅ #FIGARO-DKD trial: finerenone reduces the risk of #cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 #diabetes
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
✅ #FIDELITY Analysis: finerenone reduces the risk of #CV and renal outcomes compared to placebo in patients with type 2 #diabetes and all stages of kidney disease
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫
📖#ESCCongress
✨Join Us✨
📲 http://tttttt.me/Irathero 💫